Far Eastern Biotech Announces Endorsement Guarantee to Subsidiary Reaches Threshold under Paragraph 4, Article 25, Clause 1 of the Handling Principles for Loans and Endorsement Guarantees by Publicly Issued Companies
NQ Score
83/100
N1 Content Completeness
9
AI Summary (NQ-processed)
Far Eastern Biotech has announced a new endorsement guarantee of NT$947.4 million to its indirect subsidiary, Bora Pharmaceuticals Inc. As of the event date, the total guarantee balance stands at NT$947.4 million, representing 101.09% of the company's net equity.
AI Analysis
Frequently Asked Questions
- Q: What is Far Eastern Biotech?
- A: A Taiwanese pharmaceutical company with global operations through subsidiaries.
- Q: Is a guarantee exceeding net equity risky?
- A: Yes, it increases financial exposure and requires careful monitoring.
- Q: What does Bora Pharmaceuticals do?
- A: It is a 100% subsidiary focused on drug development and manufacturing.